BlackRock Fund Advisors’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $11.3M | Buy |
1,580,116
+190,713
| +14% | +$1.37M | ﹤0.01% | 2498 |
|
|
2016
Q3 | $13M | Buy |
1,389,403
+80,724
| +6% | +$756K | ﹤0.01% | 2320 |
|
|
2016
Q2 | $8.27M | Buy |
1,308,679
+98,007
| +8% | +$619K | ﹤0.01% | 2514 |
|
|
2016
Q1 | $6.68M | Buy |
1,210,672
+13,402
| +1% | +$74K | ﹤0.01% | 2587 |
|
|
2015
Q4 | $6.68M | Sell |
1,197,270
-83,354
| -7% | -$465K | ﹤0.01% | 2681 |
|
|
2015
Q3 | $10.8M | Buy |
1,280,624
+43,185
| +3% | +$365K | ﹤0.01% | 2343 |
|
|
2015
Q2 | $18.7M | Sell |
1,237,439
-7,239
| -0.6% | -$109K | ﹤0.01% | 2150 |
|
|
2015
Q1 | $19.9M | Buy |
1,244,678
+39,056
| +3% | +$625K | ﹤0.01% | 2073 |
|
|
2014
Q4 | $21.5M | Buy |
1,205,622
+529,960
| +78% | +$9.44M | 0.01% | 2029 |
|
|
2014
Q3 | $6.78M | Buy |
675,662
+73,108
| +12% | +$734K | ﹤0.01% | 2573 |
|
|
2014
Q2 | $9.41M | Buy |
602,554
+376,739
| +167% | +$5.88M | ﹤0.01% | 2458 |
|
|
2014
Q1 | $4.19M | Buy |
225,815
+44,899
| +25% | +$833K | ﹤0.01% | 2927 |
|
|
2013
Q4 | $3.46M | Sell |
180,916
-3,706
| -2% | -$70.8K | ﹤0.01% | 3011 |
|
|
2013
Q3 | $3.02M | Buy |
+184,622
| New | +$3.02M | ﹤0.01% | 3044 |
|